全文获取类型
收费全文 | 550篇 |
免费 | 36篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 33篇 |
妇产科学 | 15篇 |
基础医学 | 59篇 |
口腔科学 | 9篇 |
临床医学 | 43篇 |
内科学 | 131篇 |
皮肤病学 | 8篇 |
神经病学 | 50篇 |
特种医学 | 17篇 |
外科学 | 70篇 |
综合类 | 11篇 |
预防医学 | 26篇 |
眼科学 | 19篇 |
药学 | 41篇 |
肿瘤学 | 51篇 |
出版年
2023年 | 17篇 |
2022年 | 3篇 |
2021年 | 19篇 |
2020年 | 9篇 |
2019年 | 10篇 |
2018年 | 17篇 |
2017年 | 16篇 |
2016年 | 17篇 |
2015年 | 20篇 |
2014年 | 20篇 |
2013年 | 30篇 |
2012年 | 46篇 |
2011年 | 41篇 |
2010年 | 29篇 |
2009年 | 21篇 |
2008年 | 39篇 |
2007年 | 34篇 |
2006年 | 28篇 |
2005年 | 17篇 |
2004年 | 23篇 |
2003年 | 18篇 |
2002年 | 17篇 |
2001年 | 2篇 |
2000年 | 4篇 |
1999年 | 8篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1994年 | 2篇 |
1993年 | 4篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1975年 | 3篇 |
1974年 | 2篇 |
1973年 | 6篇 |
1972年 | 2篇 |
1971年 | 2篇 |
1970年 | 3篇 |
1968年 | 2篇 |
1966年 | 4篇 |
1910年 | 1篇 |
排序方式: 共有587条查询结果,搜索用时 62 毫秒
1.
2.
Shrikant Srivastava Ak Agarwal Mukul Sharma 《International journal of psychiatry in clinical practice》2013,17(3):167-171
INTRODUCTION: Clozapine is a first-line drug for treatment-resistant schizophrenia, but studies dealing with long-term outcome are lacking, so we decided to carry out such a study. METHODS: Patients with treatment-resistant schizophrenia who were recruited in an open-label study three years ago were re-evaluated using the same parameters: BPRS, PANSS and a side-effect rating checklist. RESULTS: Nineteen out of 25 patients who participated in the initial study were available for re-evaluation. Two patients had changed to conventional neuroleptic medication, and were excluded from the study. A significant reduction in psychopathology was observed in 85% of patients. An improvement in social functioning was evident, with seven patients pursuing a career independently, and another six working with their family members since being started on clozapine. All the patients were on clozapine monotherapy, and the average daily dose was 248.21 mg. No patient required hospitalization and there was no incidence of granulocytopenia. CONCLUSIONS: A significant improvement in the psychopathology and social functioning of patients was observed with much lower doses of clozapine than has been reported elsewhere. The doses used for maintenance were lower than those used in the acute phase of treatment. (Int J Psych Clin Pract 2002; 6: 167-171 ) 相似文献
3.
4.
5.
Archana S. Nimbalkar Vivek V. Shukla Ajay G. Phatak Somashekhar M. Nimbalkar 《Indian pediatrics》2013,50(4):408-410
Health status of neonates in urban slums has not been studied in smaller towns. A questionnaire was administered to 154 families of 10 urban slums of Anand (population — 197351) and 160 families from 6 villages of Anand district. The socioeconomic and education status of the slum dwellers versus rural participants were significantly lower (P<0.001). Antenatal care (79.9 vs 94.4%, P<0.001), hospital delivery (82.5 vs 93.8%, P=0.002), neonatal follow-up (27.9 vs 78.8%, P<0.001), health seeking (56.5 vs 91.3%, P<0.001), essential newborn care and exclusive breastfeeding (6.5 vs 85.6%, P<0.001) were also lower in urban slums, as compared to villages, Care seeking was low in urban slums, Hindus and illiterate mothers. Health care and socioeconomic status of neonates in slums of smaller cities is poorer than in surrounding villages. 相似文献
6.
7.
Real‐time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta‐analysis 下载免费PDF全文
8.
Delea TE Hagiwara M Thomas SK Baladi JF Phatak PD Coates TD 《American journal of hematology》2008,83(4):263-270
Deferoxamine mesylate (DFO) reduces morbidity and mortality associated with transfusional iron overload. Data on the utilization and costs of care among U.S. patients receiving DFO in typical clinical practice are limited however. This was a retrospective study using a large U.S. health insurance claims database spanning 1/97-12/04 and representing 40 million members in >70 health plans. Study subjects (n = 145 total, 106 sickle cell disease [SCD], 39 thalassemia) included members with a diagnosis of thalassemia or SCD, one or more transfusions (whole blood or red blood cells), and one or more claims for DFO. Mean transfusion episodes were 12 per year. Estimated mean DFO use was 307 g/year. Central venous access devices were required by 20% of patients. Cardiac disease was observed in 16% of patients. Mean total medical costs were $59,233 per year including $10,899 for DFO and $8,722 for administration of chelation therapy. In multivariate analyses, potential complications of iron overload were associated with significantly higher medical care costs. In typical clinical practice, use of DFO in patients with thalassemia and SCD receiving transfusions is low. Administration costs represent a large proportion of the cost of chelation therapy. Potential complications of iron overload are associated with increased costs. 相似文献
9.
10.
Shrikant R Mulay Dana Thomasova Mi Ryu Onkar P Kulkarni Adriana Migliorini Hauke Bruns Regina Gröbmayr Elena Lazzeri Laura Lasagni Helen Liapis Paola Romagnani Hans‐Joachim Anders 《The Journal of pathology》2013,230(3):322-335
Podocyte apoptosis as a pathway of podocyte loss is often suspected but rarely detected. To study podocyte apoptosis versus inflammatory forms of podocyte death in vivo, we targeted murine double minute (MDM)‐2 for three reasons. First, MDM2 inhibits p53‐dependent apoptosis; second, MDM2 facilitates NF‐κB signalling; and third, podocytes show strong MDM2 expression. We hypothesized that blocking MDM2 during glomerular injury may trigger p53‐mediated podocyte apoptosis, proteinuria, and glomerulosclerosis. Unexpectedly, MDM2 blockade in early adriamycin nephropathy of Balb/c mice had the opposite effect and reduced intra‐renal cytokine and chemokine expression, glomerular macrophage and T‐cell counts, and plasma creatinine and blood urea nitrogen levels. In cultured podocytes exposed to adriamycin, MDM2 blockade did not trigger podocyte death but induced G2/M arrest to prevent aberrant nuclear divisions and detachment of dying aneuploid podocytes, a feature of mitotic catastrophe in vitro and in vivo. Consistent with these observations, 12 of 164 consecutive human renal biopsies revealed features of podocyte mitotic catastrophe but only in glomerular disorders with proteinuria. Furthermore, delayed MDM2 blockade reduced plasma creatinine levels, blood urea nitrogen, tubular atrophy, interstitial leukocyte numbers, and cytokine expression as well as interstitial fibrosis. Together, MDM2‐mediated mitotic catastrophe is a previously unrecognized variant of podocyte loss where MDM2 forces podocytes to complete the cell cycle, which in the absence of cytokinesis leads to podocyte aneuploidy, mitotic catastrophe, and loss by detachment. MDM2 blockade with nutlin‐3a could be a novel therapeutic strategy to prevent renal inflammation, podocyte loss, glomerulosclerosis, proteinuria, and progressive kidney disease. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 相似文献